Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Zentralblatt Fur Gynakologie
|
November 21, 1998
[Iatrogenic androgenization]
R Mangold, V Heilmann, W G Rossmanith
European Radiology
|
July 12, 2002
Breast MRI for monitoring response of primary breast cancer to neo-adjuvant chemotherapy
A Rieber, H-J Brambs, A Gabelmann, et al.
Human Genetics
|
June 1, 1994
Multiplex PCR screening detects small p53 deletions and insertions in human ovarian cancer cell lines
I B Runnebaum, X W Tong, V Moebus, et al.
International Journal of Cancer
|
April 3, 2001
Detection of integrated papillomavirus sequences by ligation-mediated PCR (DIPS-PCR) and molecular characterization in cervical cancer cells
F Luft, R Klaes, M Nees, et al.
Der Radiologe
|
October 20, 1999
[Interventional treatment of hemorrhages in advanced cervical carcinoma]
S C Krämer, J Görich, N Rilinger, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
July 19, 2005
Neuroprotection with amifostine in the first-line treatment of advanced ovarian cancer with carboplatin/paclitaxel-based chemotherapy--a double-blind, placebo-controlled, randomized phase II study from the Arbeitsgemeinschaft Gynäkologische Onkologoie (AGO) Ovarian Cancer Study Group
F Hilpert, A Stähle, O Tomé, et al.
Journal of Cancer Research and Clinical Oncology
|
August 24, 2004
Primary chemotherapy with doxorubicin and paclitaxel in patients with early breast cancer: final results of a multicenter phase II study
P Schmid, J Krocker, G Morack, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 29, 2006
The anti-idiotypic antibody abagovomab in patients with recurrent ovarian cancer. A phase I trial of the AGO-OVAR
J Pfisterer, A du Bois, J Sehouli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 21, 2005
Primary chemotherapy with gemcitabine as prolonged infusion, non-pegylated liposomal doxorubicin and docetaxel in patients with early breast cancer: final results of a phase II trial
P Schmid, J Krocker, C Jehn, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Zentralblatt Fur Gynakologie
|
November 21, 1998
[Iatrogenic androgenization]
R Mangold, V Heilmann, W G Rossmanith
European Radiology
|
July 12, 2002
Breast MRI for monitoring response of primary breast cancer to neo-adjuvant chemotherapy
A Rieber, H-J Brambs, A Gabelmann, et al.
Human Genetics
|
June 1, 1994
Multiplex PCR screening detects small p53 deletions and insertions in human ovarian cancer cell lines
I B Runnebaum, X W Tong, V Moebus, et al.
International Journal of Cancer
|
April 3, 2001
Detection of integrated papillomavirus sequences by ligation-mediated PCR (DIPS-PCR) and molecular characterization in cervical cancer cells
F Luft, R Klaes, M Nees, et al.
Der Radiologe
|
October 20, 1999
[Interventional treatment of hemorrhages in advanced cervical carcinoma]
S C Krämer, J Görich, N Rilinger, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
July 19, 2005
Neuroprotection with amifostine in the first-line treatment of advanced ovarian cancer with carboplatin/paclitaxel-based chemotherapy--a double-blind, placebo-controlled, randomized phase II study from the Arbeitsgemeinschaft Gynäkologische Onkologoie (AGO) Ovarian Cancer Study Group
F Hilpert, A Stähle, O Tomé, et al.
Journal of Cancer Research and Clinical Oncology
|
August 24, 2004
Primary chemotherapy with doxorubicin and paclitaxel in patients with early breast cancer: final results of a multicenter phase II study
P Schmid, J Krocker, G Morack, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 29, 2006
The anti-idiotypic antibody abagovomab in patients with recurrent ovarian cancer. A phase I trial of the AGO-OVAR
J Pfisterer, A du Bois, J Sehouli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 21, 2005
Primary chemotherapy with gemcitabine as prolonged infusion, non-pegylated liposomal doxorubicin and docetaxel in patients with early breast cancer: final results of a phase II trial
P Schmid, J Krocker, C Jehn, et al.
Page
of 1